Innova Captab Limited
Kotak Mutual Fund reduced its stake in Innova Captab Limited from 3.64% to 3.47%, selling 1,02,590 shares.
An integrated pharmaceutical company operating across India's drug manufacturing and distribution value chain. Innova Captab develops, manufactures, and markets a diverse portfolio of pharmaceutical formulations for both domestic and international markets. The company maintains vertically integrated operations spanning multiple therapeutic areas, enabling control over production processes, quality management, and supply chain efficiency within the competitive Indian pharmaceutical sector.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.